News summary

OAC Calls on Cigna to Listen to Employees and Restore GLP-1 Coverage

Source: PR Newswire • Published: 02 Oct 2026, 12:15

Summarized by Masters of Longevity from PR Newswire.

Coverage debate about GLP-1s as employees push an insurer to restore benefits — a news article outlining advocacy, employee reactions, and calls for reversal.

OAC Calls on Cigna to Listen to Employees and Restore GLP-1 Coverage
Key Takeaways
  • 2, 2026 /PRNewswire/ -- The Obesity Action Coalition (OAC) is calling on Cigna to listen to its employees and reconsider its decision to end coverage of GLP-1 medications for weight management.
  • In June, Cigna notified more than 50,000 U.S.
  • Employees that its health plan would stop covering GLP-1 medications for weight management.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.